Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 99Recruiting 50Active not recruiting 30Terminated 21Unknown 20Withdrawn 8Not yet recruiting 4No longer available 2Temporarily not available 1Suspended 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 7Osteosarcoma 4Lymphoma 3Prostatic Neoplasms 2Neoplasm Metastasis 2Melanoma 2Gliosarcoma 2Glioblastoma 2Gastrointestinal Stromal Tumors 2Dendritic Cell Sarcoma, Interdigitating 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neuroblastoma 1Leukemia 1Histiocytic Sarcoma 1Glioma 1Gallbladder Neoplasms 1Eyelid Squamous Cell Carcinoma 1Endometrial Neoplasms 1

Interventions

Vincristine 1Temozolomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Sarcoma, Ewing × Sarcoma × Clear all
NCT04890093 2026-03-16

Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1/2 Suspended
64 enrolled
Sarcoma

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡